ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 1 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $97,000 | +1112.5% | 275,000 | +756.7% | 0.00% | – |
| Q2 2019 | $8,000 | -46.7% | 32,100 | 0.0% | 0.00% | – |
| Q1 2019 | $15,000 | +25.0% | 32,100 | 0.0% | 0.00% | – |
| Q4 2018 | $12,000 | -90.6% | 32,100 | -81.4% | 0.00% | -100.0% |
| Q3 2018 | $128,000 | +16.4% | 172,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $110,000 | +74.6% | 172,300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $63,000 | -44.7% | 172,300 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $114,000 | +15.2% | 172,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $99,000 | -74.8% | 172,300 | -46.5% | 0.00% | -80.0% |
| Q2 2017 | $393,000 | +8.3% | 322,300 | +34.2% | 0.01% | +25.0% |
| Q1 2017 | $363,000 | +72.9% | 240,200 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $210,000 | -35.2% | 240,200 | 0.0% | 0.00% | -40.0% |
| Q3 2016 | $324,000 | -23.8% | 240,200 | 0.0% | 0.01% | -28.6% |
| Q2 2016 | $425,000 | -11.1% | 240,200 | 0.0% | 0.01% | -12.5% |
| Q1 2016 | $478,000 | -7.5% | 240,200 | +49.9% | 0.01% | -20.0% |
| Q4 2015 | $517,000 | +82.0% | 160,200 | 0.0% | 0.01% | +66.7% |
| Q3 2015 | $284,000 | -6.0% | 160,200 | +40.5% | 0.01% | 0.0% |
| Q2 2015 | $302,000 | +0.3% | 114,043 | +123.0% | 0.01% | -14.3% |
| Q4 2014 | $301,000 | -22.4% | 51,151 | -11.6% | 0.01% | -30.0% |
| Q3 2014 | $388,000 | +90.2% | 57,895 | +104.6% | 0.01% | +100.0% |
| Q2 2014 | $204,000 | – | 28,295 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |